After seeing the trial oncologist, I am scheduled to have the required CT scans part of the screening process (up to 6 weeks) of this Lu-177 clinical study.
The randomized study (32 weeks) will have arm A and arm B (abiraterone or enzalutamide) with crossover eligibility. I am concerned if I get assigned to arm B and moving the possible treatment well too late down the road if I change as requested from Abiraterone to Enzalutamide.
If I change to Enzalutamide (Xtandi) during the screening process I need to pay the massive Xtandi bill as my Part D doesn't help that much, especially during the first few months.
Any suggestion to get Xtandi at a lower cost, meaning not through Part D?